PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer Patients
Sponsor: National Cancer Institute (NCI)
This observational or N/A phase trial investigates Oropharynx Cancer and Squamous Cell Carcinoma and is currently completed. National Cancer Institute (NCI) leads this study, which shows 17 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
17 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2022 — Jul 2024 [monthly]
Completed
-
Jun 2022 — Dec 2022 [monthly]
Completed
-
Jan 2022 — Jun 2022 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 12 earlier versions
-
Jun 2021 — Jan 2022 [monthly]
Active Not Recruiting
-
Feb 2021 — Jun 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
-
Aug 2020 — Dec 2020 [monthly]
Recruiting
Status: Suspended → Recruiting
-
Apr 2020 — Aug 2020 [monthly]
Suspended
Status: Recruiting → Suspended
-
Jan 2020 — Apr 2020 [monthly]
Recruiting
-
Jun 2019 — Jan 2020 [monthly]
Recruiting
-
Jul 2018 — Jun 2019 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- National Institute of Dental and Craniofacial Research (NIDCR)
- University of Wisconsin, Madison
For direct contact, visit the study record on ClinicalTrials.gov .